Vertex Pharmaceuticals revenue and financials
In the fiscal year ended December 2025, Vertex Pharmaceuticals reported revenue of $12B (+8.90% year over year). Net income was $3.95B, a net margin of 32.9%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +8.90%
- 2025 vs 2024
- Net margin
- 32.9%
- 2024: -4.9%
How Vertex Pharmaceuticals is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 14.1% a year on average over the last 5 years
Compound annual growth rate: from $6.21B in 2020 to $12B in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 48.2% to 34.8%
Operating income over revenue, 2022 → 2025: 13.5 percentage points.
Free cash flow equal to 82% of net income
Totals for fiscal years 2023–2025: free cash flow $5.74B, net income $7.04B.
Profitable in 4 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12,001 | 11,020 | 9,869 | 8,931 | 7,574 | 6,206 | 4,163 | 3,048 | 2,489 | 1,702 |
| Cost of revenue | 1,651 | 1,531 | 1,262 | 1,080 | 904 | 736 | 548 | 410 | 275 | 210 |
| Gross profit | 6,441 | 5,859 | 5,444 | 5,323 | 4,732 | 3,825 | 1,861 | 1,222 | 889 | 444 |
| Selling, general and administrative | 1,753 | 1,464 | 1,137 | 945 | 840 | 771 | 659 | 558 | 496 | 433 |
| Research and development | 4,043 | 8,259 | 3,690 | 2,656 | 3,051 | 1,830 | 1,755 | 1,416 | 1,325 | 1,048 |
| Operating income | 4,173 | -233 | 3,832 | 4,307 | 2,782 | 2,856 | 1,198 | 635 | 123 | 9.9 |
| EBIT | 4,687 | 4,395 | 4,308 | 4,378 | 3,892 | 3,054 | 1,202 | 664 | 393 | 11.2 |
| EBITDA | 4,866 | 4,577 | 4,477 | 4,527 | 4,018 | 3,164 | 1,309 | 736 | 454 | 72.6 |
| Interest expense | 13.3 | 30.6 | 44.1 | 54.8 | 61.5 | 58.2 | 58.5 | 72.5 | 69.3 | 81.4 |
| Pre-tax income | 4,643 | 249 | 4,380 | 4,232 | 2,730 | 3,117 | 1,395 | 600 | -15.7 | -67.4 |
| Income tax | 690 | 784 | 760 | 910 | 388 | 405 | 218 | -1,487 | -107 | 16.7 |
| Net income | 3,953 | -536 | 3,620 | 3,322 | 2,342 | 2,712 | 1,177 | 2,097 | 263 | -112 |
| Net income to common shareholders | 3,953 | -536 | 3,620 | 3,322 | 2,342 | 2,712 | 1,177 | 2,096 | 263 | -112 |
| Basic EPS | 15.46 | -2.08 | 14.05 | 12.97 | 9.09 | 10.44 | 4.58 | 8.24 | 1.06 | -0.46 |
| Diluted EPS | 15.32 | -2.08 | 13.89 | 12.82 | 9.01 | 10.29 | 4.51 | 8.09 | 1.04 | -0.46 |
| Average shares (basic) | 256 | 258 | 258 | 256 | 258 | 260 | 257 | 254 | 249 | 245 |
| Average shares (diluted) | 258 | 258 | 261 | 259 | 260 | 263 | 261 | 259 | 253 | 245 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3,441 | 3,334 | 2,987 | 3,190 | 3,076 | 2,965 | 2,770 | 2,912 | 2,772 | 2,646 | 2,691 | 2,518 |
| Cost of revenue | 1,576 | 1,483 | 1,354 | 1,440 | 1,393 | 1,386 | 1,343 | 1,422 | 1,269 | 1,339 | 1,132 | 1,193 |
| Gross profit | 1,865 | 1,851 | 1,633 | 1,750 | 1,684 | 1,579 | 1,428 | 1,490 | 1,503 | 1,307 | 1,559 | 1,325 |
| Selling, general and administrative | 641 | 582 | 494 | 487 | 445 | 425 | 396 | 378 | 372 | 372 | 343 | 369 |
| Research and development | 1,321 | 994 | 962 | 1,107 | 978 | — | — | — | — | — | — | — |
| Operating income | 1,224 | 1,269 | 1,139 | 1,263 | 1,239 | 1,154 | 1,031 | 1,112 | 1,132 | 935 | 1,216 | 956 |
| EBIT | 1,224 | 1,269 | 1,139 | 1,263 | 1,239 | 1,154 | 1,031 | 1,112 | 1,132 | 935 | 1,216 | 956 |
| EBITDA | 1,293 | 1,325 | 1,195 | 1,288 | 1,293 | 1,206 | 1,080 | 1,134 | 1,185 | 989 | 1,270 | 1,003 |
| Interest expense | 36.0 | — | — | 3.3 | 3.3 | 3.7 | 3.0 | 2.8 | 7.5 | 9.9 | 10.4 | 10.6 |
| Pre-tax income | 783 | 1,392 | 1,253 | 1,331 | 1,299 | 1,283 | 730 | 1,137 | 1,224 | -3,391 | 1,279 | 1,148 |
| Income tax | 130 | 292 | 222 | 140 | 216 | 250 | 84.1 | 224 | 179 | 202 | 180 | 179 |
| Net income | 654 | 1,100 | 1,031 | 1,191 | 1,083 | 1,033 | 646 | 913 | 1,045 | -3,594 | 1,100 | 969 |
| Net income to common shareholders | 654 | 1,100 | 1,031 | 1,191 | 1,083 | 1,033 | 646 | 913 | 1,045 | -3,594 | 1,100 | 969 |
| Basic EPS | 2.58 | 4.34 | 4.06 | 4.69 | 4.24 | 4.02 | 2.52 | 3.55 | 4.05 | -13.92 | 4.26 | 3.76 |
| Diluted EPS | 2.56 | 4.31 | 4.02 | 4.65 | 4.20 | 3.99 | 2.49 | 3.50 | 4.01 | -13.92 | 4.21 | 3.71 |
| Average shares (basic) | 254 | 254 | 254 | 254 | 256 | 257 | 257 | 258 | 258 | 258 | 258 | 258 |
| Average shares (diluted) | 255 | 255 | 256 | 256 | 258 | 259 | 260 | 261 | 261 | 258 | 261 | 261 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 25,643 | 22,533 | 22,730 | 18,151 | 13,433 | 11,752 | 8,318 | 6,246 | 3,546 | 2,897 |
| Current assets | 11,201 | 9,596 | 14,144 | 13,235 | 9,561 | 8,133 | 4,823 | 3,843 | 2,649 | 1,832 |
| Cash and equivalents | 5,085 | 4,570 | 10,369 | 10,504 | 6,795 | 5,988 | 3,109 | 2,650 | 1,665 | 1,184 |
| Short-term investments | 1,523 | 1,546 | 849 | 275 | 730 | 671 | 699 | 518 | 423 | 251 |
| Receivables | 2,053 | 1,609 | 1,563 | 1,442 | 1,137 | 885 | 634 | 410 | 384 | 220 |
| Inventory | 1,687 | 1,205 | 739 | 461 | 353 | 281 | 168 | 124 | 112 | 77.6 |
| Net property, plant and equipment | 3,083 | 2,585 | 1,453 | 1,456 | 1,424 | 1,284 | 833 | 812 | 789 | 698 |
| Goodwill | 1,088 | 1,088 | 1,088 | 1,088 | 1,002 | 1,002 | 1,002 | 50.4 | 50.4 | 50.4 |
| Other intangible assets | 424 | 826 | 840 | 604 | 400 | 400 | 400 | — | 29.0 | 284 |
| Long-term investments | 5,794 | 5,173 | 2,498 | 112 | — | — | — | — | — | 20.3 |
| Current liabilities | 3,861 | 3,565 | 3,547 | 2,742 | 2,142 | 1,878 | 1,335 | 1,120 | 807 | 793 |
| Accounts payable | 462 | 413 | 365 | 304 | 195 | 155 | 87.6 | 111 | 74.0 | 61.5 |
| Total debt | 2,036 | 1,750 | 808 | 900 | 967 | 942 | 673 | 587 | 606 | 541 |
| Total liabilities | 6,977 | 6,124 | 5,150 | 4,238 | 3,333 | 3,065 | 2,233 | 1,811 | 1,504 | 1,559 |
| Total equity (incl. minority) | 18,666 | 16,410 | 17,580 | 13,913 | 10,100 | 8,687 | 6,085 | 4,435 | 2,042 | 1,338 |
| Retained earnings | 13,560 | 9,607 | 10,142 | 6,523 | 3,201 | 859 | -1,853 | -2,989 | -5,120 | -5,374 |
| Minority interest | — | — | — | — | — | — | — | — | 13.7 | 182 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32,736 | 27,423 | 26,484 | 25,643 | 24,862 | 24,037 | 22,881 | 22,533 | 22,240 | 20,132 | 23,917 | 22,730 |
| Current assets | 11,686 | 12,544 | 11,730 | 11,201 | 10,570 | 10,428 | 10,009 | 9,596 | 9,804 | 8,942 | 13,289 | 14,144 |
| Cash and equivalents | 4,979 | 6,144 | 5,493 | 5,085 | 4,940 | 4,972 | 4,675 | 4,570 | 5,239 | 4,580 | 9,158 | 10,369 |
| Short-term investments | 1,324 | 1,709 | 1,754 | 1,523 | 1,347 | 1,411 | 1,527 | 1,546 | 1,285 | 1,215 | 1,013 | 849 |
| Receivables | 2,311 | 2,134 | 1,996 | 2,053 | 1,946 | 1,894 | 1,805 | 1,609 | 1,751 | 1,656 | 1,793 | 1,563 |
| Inventory | 2,245 | 1,765 | 1,767 | 1,687 | 1,627 | 1,499 | 1,360 | 1,205 | 1,080 | 915 | 813 | 739 |
| Net property, plant and equipment | 3,329 | 3,328 | 3,294 | 3,083 | 3,017 | 2,649 | 2,634 | 2,585 | 2,514 | 1,771 | 1,486 | 1,453 |
| Goodwill | 2,423 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 | 1,088 |
| Other intangible assets | 8,518 | 413 | 419 | 424 | 430 | 436 | 441 | 826 | 832 | 838 | 835 | 840 |
| Long-term investments | 3,606 | 5,869 | 5,831 | 5,794 | 5,804 | 5,712 | 5,221 | 5,173 | 4,778 | 4,478 | 4,456 | 2,498 |
| Current liabilities | 5,000 | 3,938 | 3,881 | 3,861 | 4,475 | 4,138 | 3,783 | 3,565 | 3,973 | 3,547 | 3,796 | 3,547 |
| Accounts payable | 473 | 430 | 489 | 462 | 420 | 442 | 445 | 413 | 396 | 328 | 351 | 365 |
| Long-term debt | 3,497 | — | — | — | — | — | — | — | — | — | — | — |
| Total debt | 5,479 | 1,978 | 1,987 | 2,036 | 1,835 | 1,527 | 1,649 | 1,750 | 1,774 | 933 | 721 | — |
| Total liabilities | 11,829 | 7,175 | 7,123 | 6,977 | 7,544 | 6,861 | 6,384 | 6,124 | 6,609 | 5,357 | 5,371 | 5,150 |
| Total equity (incl. minority) | 20,907 | 20,248 | 19,362 | 18,666 | 17,319 | 17,175 | 16,496 | 16,410 | 15,631 | 14,775 | 18,547 | 17,580 |
| Retained earnings | 16,345 | 15,691 | 14,591 | 13,560 | 12,369 | 11,286 | 10,253 | 9,607 | 8,694 | 7,648 | 11,242 | 10,142 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3,631 | -493 | 3,537 | 4,130 | 2,644 | 3,254 | 1,569 | 1,270 | 845 | 236 |
| Depreciation and amortization | 210 | 207 | 181 | 148 | 126 | 110 | 107 | 72.4 | 61.4 | 61.4 |
| Capital expenditure | -438 | -298 | -200 | -205 | -235 | -260 | -75.4 | -95.4 | -99.4 | -56.6 |
| Investing cash flow | -945 | -3,770 | -3,142 | -321 | -341 | 99.4 | -1,235 | -202 | -483 | 51.2 |
| Financing cash flow | -2,261 | -1,495 | -562 | -67.7 | -1,478 | -505 | 127 | -71.2 | 68.4 | 133 |
| Share repurchases | -2,017 | -1,177 | -428 | 0.0 | -1,425 | -539 | -186 | -350 | 0.0 | 0.0 |
| Debt issued | — | — | 1.8 | 0.0 | 28.3 | 13.3 | 10.0 | 20.8 | 34.7 | 86.2 |
| Debt repaid | -5.4 | -33.6 | -44.9 | -85.5 | -47.0 | -42.3 | -39.2 | -33.4 | -324 | -93.0 |
| Effect of exchange rates | 90.9 | -42.6 | 26.9 | -29.2 | -13.4 | 20.6 | 1.6 | -6.2 | 5.8 | -4.7 |
| Net change in cash | 516 | -5,800 | -140 | 3,712 | 811 | 2,868 | 462 | 991 | 436 | 416 |
| Free cash flow | 3,194 | -790 | 3,337 | 3,925 | 2,409 | — | — | — | — | — |
| Levered free cash flow | 2,573 | 2,800 | 3,510 | 3,307 | 2,402 | 2,232 | 937 | 887 | 446 | 223 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 643 | 1,125 | 1,428 | 498 | 1,241 | 1,073 | 819 | 585 | 1,370 | -3,754 | 1,307 | 235 |
| Depreciation and amortization | 69.2 | 56.5 | 55.9 | 24.5 | 54.0 | 51.7 | 48.4 | 21.3 | 53.2 | 54.0 | 53.5 | 47.2 |
| Capital expenditure | -97.3 | -112 | -133 | -149 | -102 | -146 | -40.7 | -92.6 | -67.7 | -69.0 | -68.4 | -58.1 |
| Investing cash flow | -6,101 | -45.8 | -432 | -288 | -117 | -485 | -55.8 | -822 | -348 | -464 | -2,136 | -887 |
| Financing cash flow | 4,297 | -427 | -539 | -77.2 | -1,155 | -349 | -680 | -391 | -388 | -359 | -358 | -120 |
| Share repurchases | -206 | -474 | -565 | -131 | -1,162 | -398 | -697 | -425 | -391 | -401 | -365 | -153 |
| Debt issued | 4,497 | — | — | — | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | -1.4 | -1.4 | -1.3 | -1.3 | -1.3 | -5.4 | -13.7 | -13.2 | -12.0 |
| Effect of exchange rates | -4.9 | -3.7 | -40.3 | 7.3 | -4.1 | 57.2 | 30.5 | -47.3 | 22.8 | -2.5 | -15.6 | 27.4 |
| Net change in cash | -1,166 | 649 | 417 | 140 | -34.2 | 297 | 113 | -676 | 657 | -4,578 | -1,203 | -744 |
| Free cash flow | 546 | 1,013 | 1,295 | 349 | 1,140 | 927 | 778 | 492 | 1,302 | -3,823 | 1,238 | 177 |
| Levered free cash flow | 728 | 757 | 1,012 | -156 | 1,019 | 912 | 802 | 185 | 1,094 | 630 | 891 | 448 |
Financial statements of similar companies
Companies in the group: same industry, similar size
